Volume 37, Issue 3, September 2023
Congenital Disease
Original article
Model-driven survival prediction after congenital heart surgery
Assessing the risk of congenital heart surgery has evolved in recent years from being purely consensus-derived [1, 2] to being based on empirical tools such as the Society of Thoracic Surgeons–European Association for Cardio-Thoracic Surgery (STAT) congenital heart surgery mortality categories [3].
Ventriculo-arterial coupling for predicting cardiac index increase in infants after heart surgery
Children with congenital heart disease (CHD) often require heart surgery at a young age.
Invited Commentary
Milrinone, we all like you …
Coronary Disease
Original article
Body mass index effect on long-term survival after coronary artery bypass surgery: a competing risk analysis
In 2016, nearly 2 billion adults were overweight, of whom over 650 million were obese [1].
General Interest
Original article
Importance of personal development for a diverse workforce in thoracic surgery: the art of Curriculum Vitae building and interviewing
Thoracic Non-oncology
Original article
Bronchial branching patterns and volumetry in the right upper lobe: impact on segmentectomy planning
Segmentectomy is associated with significant preservation of pulmonary function.
Impact of gastro-jejunostomy tube in lung transplant patients: a propensity-matched analysis
Enteral nutrition is essential in the care of critically ill patients, including lung transplant patients [1].
Thoracic Oncology
Original article
Experimental and histological evaluation of different clamp technique for pulmonary artery
Pulmonary artery clamping using a vascular clamp on an extended incision or an open conversion has traditionally been the gold standard for patients with intraoperative bleeding or severe adhesions during thoracoscopic anatomical lung resection (ALR) [1, 2].
May the clamp be with you
The clinical-histologic and prognostic characteristics in patients with a second primary non-small-cell lung cancer after a lobectomy
Lung cancer has become the second most commonly diagnosed type of cancer after female breast cancer but remains the leading cause of cancer deaths [1].
Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer
Lobectomy has been the recommended surgical procedure for early-stage non-small-cell lung cancer (NSCLC) for a long time after a randomized trial was published by the Lung Cancer Study Group [1].
Invited Commentary
Segmentectomy for stage IA3 tumours: just another day in clinic
Valvular Heart Disease
Case report
Staged endoscopic mitral valve repair for active infective endocarditis with a mitral annular abscess
In young women, mitral valve repair (MVr) over replacement is particularly preferable.
Vascular Disease
Original article
Time-of-day discrepancy for the long-term surgical outcome of patients with aortic dissection
Recent evidence has shown an association between cardiovascular function and circadian rhythms [1, 2].
Mediastinal perigraft seroma after thoracic aortic surgery
Perigraft seromas (PGSs) are associated with various vascular procedures, including peripheral bypass grafting, conventional and endovascular aortic repair.
Mechanical Circulatory Support
Video
Transition from temporary to durable right ventricular support after left ventricular assist device implantation
Cardiac Arrhythmia
Original article
Cardiopulmonary bypass management and risk of new-onset atrial fibrillation after cardiac surgery
New-onset postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery.
3D mapping challenges in hybrid video-assisted thoracoscopic surgical ablation of Brugada syndrome
Brugada syndrome (BrS) is an inherited disease characterized by an increased risk of sudden cardiac death in the absence of structural heart anomalies.
Heart Failure
Invited Commentary
HM6: greater than the sum of its parts?
Case report
Systolic anterior motion due to morphology changes in constrictive pericarditis
A 74-year-old woman, with end-stage renal failure caused by IgA nephropathy, underwent haemodialysis for 2 years.